[Long-term hypolipemic therapy in arteriosclerosis obliterans].
D000368:Aged; D000924:Anticholesteremic Agents / Q000627:therapeutic use; D001162:Arteriosclerosis Obliterans / Q000097:blood / Q000188:drug therapy*; D004035:Diet Therapy; D004041:Dietary Fats / Q000008:administration & dosage; D006801:Humans; D006949:Hyperlipidemias / Q000188:drug therapy*; D008875:Middle Aged; D010426:Pentosan Sulfuric Polyester / Q000009:adverse effects / Q000627:therapeutic use*; D011134:Polysaccharides / Q000627:therapeutic use*; D013806:Theophylline / Q000031:analogs & derivatives*; D014971:Xanthinol Niacinate / Q000009:adverse effects / Q000627:therapeutic use*
D000924:Anticholesteremic Agents; D004041:Dietary Fats; D011134:Polysaccharides; D010426:Pentosan Sulfuric Polyester; D014971:Xanthinol Niacinate; D013806:Theophylline
Terapéutica hipolipemiante a largo plazo en la aterosclerosis obliterante